FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Valeant responds to drug price concerns with cuts

Valeant Pharmaceuticals cuts drug prices in new distribution deal with Walgreens. Read more

Long-awaited surgery drug gets FDA OK

Finally, Merck's Bridion is approved to reverse effects of neuromuscular blocking drugs used during surgery. Read more

CONTINUING PHARMACY EDUCATION

December 2015

MTM essentials for cough management

Pharmacists can help patients with the various management options for the most common causes of cough. More

IPF drug to be tested with add-on therapy

Boehringer Ingelheim recently began a clinical trial to assess the safety and tolerability of adding on pirfenidone to nintedanib (Ofev) for idiopathic pulmonary fibrosis (IPF) patients. Details

December 23, 2015

Oncologists not prescribing expensive cancer drugs

Sugammadex: A selective relaxant binding agent for neuromuscular block reversal

Click to contact the editorial team. Click to contact the sales team.

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us